SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. The company is headquartered in Mainz, Hessen and currently employs 4,689 full-time employees. The company went IPO on 2023-09-28. The firm is primarily engaged in designing advanced drug containment solutions and drug delivery systems for the pharmaceutical and biotech industries. The Company’s portfolio ranges from syringes and cartridges to vials and ampoules, all made using Type I Borosilicate Glass and high-grade pharmaceutical polymer.
Follow-Up Questions
SCHOTT Pharma AG & Co KgaA (STTPF) 的本益比是多少？
SCHOTT Pharma AG & Co KgaA 的本益比是 N/A
STTPF 股票的價格表現如何？
STTPF 的當前價格為 0，在上個交易日 decreased 了 0%。
SCHOTT Pharma AG & Co KgaA 的市值是多少？
SCHOTT Pharma AG & Co KgaA 的當前市值是 $0
SCHOTT Pharma AG & Co KgaA 是買入、賣出還是持有？
據華爾街分析師稱，共有 15 位分析師對 SCHOTT Pharma AG & Co KgaA 進行了分析師評級，包括 4 位強烈買入，10 位買入，3 位持有，2 位賣出，以及 4 位強烈賣出
